John F. Chin
Directeur/Bestuurslid bij ANTENGENE CORPORATION LIMITED
Vermogen: 226 343 $ op 31-05-2024
Actieve functies van John F. Chin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Directeur/Bestuurslid | 18-08-2020 | - |
| Corporate Officer/Principal | 18-08-2020 | - | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01-10-1998 | - |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | - | - |
Loopbaan van John F. Chin
Eerdere bekende functies van John F. Chin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01-01-2005 | 01-01-2020 |
Opleiding van John F. Chin
| University of Arizona | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| China | 3 |
Operationeel
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Beurs
- Insiders
- John F. Chin
- Ervaring
